Superantigens in Cancer Immunotherapy: Mechanisms, Engineering Strategies, and Therapeutic Potential

Urooj Yousaf Virk, Hafiza Aasia Malik, Muneera Anwer, Jennifer Wilson, Md. Sifat Rahi, Ming Q. Wei

Open source

DOI
10.1096/fj.202602532r
Published
2026-08-31
Container
The FASEB Journal
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1096/fj.202602532r,
  title = {Superantigens in Cancer Immunotherapy: Mechanisms, Engineering Strategies, and Therapeutic Potential},
  author = {Urooj Yousaf Virk and Hafiza Aasia Malik and Muneera Anwer and Jennifer Wilson and Md. Sifat Rahi and Ming Q. Wei},
  year = {2026},
  journal = {The FASEB Journal},
  doi = {10.1096/fj.202602532r},
  url = {https://doi.org/10.1096/fj.202602532r}
}

RIS

TY  - JOUR
TI  - Superantigens in Cancer Immunotherapy: Mechanisms, Engineering Strategies, and Therapeutic Potential
AU  - Urooj Yousaf Virk
AU  - Hafiza Aasia Malik
AU  - Muneera Anwer
AU  - Jennifer Wilson
AU  - Md. Sifat Rahi
AU  - Ming Q. Wei
PY  - 2026
JO  - The FASEB Journal
DO  - 10.1096/fj.202602532r
UR  - https://doi.org/10.1096/fj.202602532r
ER  - 

APA

Virk, U. Y., Malik, H. A., Anwer, M., Wilson, J., Rahi, M. S., & Wei, M. Q. (2026). Superantigens in Cancer Immunotherapy: Mechanisms, Engineering Strategies, and Therapeutic Potential. The FASEB Journal. https://doi.org/10.1096/fj.202602532r

Source records